524768 EMMESSA

Emmessar Biotech & Nutrition Share Price

₹44.99 +0.99 (2.25%)

23 Dec, 2024 04:24

SIP TrendupStart SIP in EMMESSA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -0.53%
  • Over 3 Month + 16.61%
  • Over 6 Month + 9.73%
  • Over 1 Year + 76.85%
SIP Lightning

Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!

Invest Now

Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Emmessar Biotech & Nutrition Financials

Emmessar Biotech & Nutrition Technicals

EMA & SMA

Current Price
₹44.99
+ 0.99 (2.25%)
pointer
  • stock-down_img
  • Bullish Moving Average 12
  • stock-up_img
  • Bearish Moving Average 4
  • 20 Day
  • ₹44.83
  • 50 Day
  • ₹45.08
  • 100 Day
  • ₹44.02
  • 200 Day
  • ₹41.06

Resistance and Support

44.33 Pivot Speed
  • R3 49.16
  • R2 47.33
  • R1 46.16
  • S1 43.16
  • S2 41.33
  • S3 40.16

What's your outlook on Emmessar Biotech & Nutrition?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emmessar Biot.& Nut. has an operating revenue of Rs. 0.82 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of 146% is great, ROE of 10% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at D- which indicates heavy supply, Group Rank of 67 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-03 Quarterly Results
2023-12-09 Quarterly Results

Emmessar Biotech & Nutrition F&O

Emmessar Biotech & Nutrition Shareholding Pattern

59.53%
0.05%
0.14%
37.48%
2.8%

About Emmessar Biotech & Nutrition

  • NSE Symbol
  • EMMESSA
  • BSE Symbol
  • 524768
  • Managing Director
  • Mr. Srinivasa Raghavan Mathurakavi Ayyangar
  • ISIN
  • INE634B01016

Similar Stocks to Emmessar Biotech & Nutrition

Emmessar Biotech & Nutrition FAQs

Emmessar Biotech & Nutrition share price is ₹44 As on 23 December, 2024 | 04:10

The Market Cap of Emmessar Biotech & Nutrition is ₹22.5 Cr As on 23 December, 2024 | 04:10

The P/E ratio of Emmessar Biotech & Nutrition is 26 As on 23 December, 2024 | 04:10

The PB ratio of Emmessar Biotech & Nutrition is 3 As on 23 December, 2024 | 04:10

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23